Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by bikkel78

IMVIF

RE:RE:RE:meeting with management

management wanted to participate in the december offering but the structure...

February 8, 2023

IMVIF

meeting with management

I had a meeting with the management and it gave me a good feeling...

February 7, 2023

IMVIF

Put pressure on the company

Sad to see they made the decision to save the prelim DLBCL data for a...

October 5, 2022

IMVIF

RE:VITALIZE Update!!??

IMV is announcing that they will present the data in a scientific conference...

September 30, 2022

IMVIF

RE:RE:RE:RE:Interesting (and hidden) data

we just have to wait :)

September 11, 2022

IMVIF

Leede Jones Gable launched coverage of IMV - $ 10.50 PT

Leede Jones Gable launched coverage of IMV (TSX:IMV) with a...

December 16, 2020

IMVIF

Breakthrough Status for DLBCL

I spoke to the company and they are convinced they will get Breakthrough...

December 10, 2020

IMVIF

RE:RE:RE:DLBCL thoughts?

also, looking at yesterdays PR, they will also focus on  PD-L1 in de...

December 7, 2020

IMVIF

RE:Some of the independent investigator trials

The company has 2 years of cash, the perfect position to enter discussions on...

December 2, 2020

IMVIF

Biomarker in basket trial?

I think / would be logical, to see if the PD-L1 expression is associated with...

November 20, 2020

IMVIF

Key milestones H2 2020

Key Upcoming Clinical Milestones - Initiation of Phase 1/2 clinical trial...

October 26, 2020

IMVIF

RE:RE:RE:RE:RE:RE:RE:Medicago to get 173m in funding from Canada Gov

For Medicago it is great news. They really needed that money as they have a...

October 26, 2020

IMVIF

RE:RE:could it be

I spoke to company, they provided all that was needed. so the delay is 100...

September 25, 2020

IMVIF

Merck and DLBCL...partnership coming?

https://investor.seattlegenetics.com/press-releases/news-details/2020/Seattle...

September 14, 2020

IMVIF

RE:RE:RE:RE:Haven't posted in a while

no I missed the call....but the price reaction was good so I gueass our...

September 10, 2020

IMVIF

RE:New presentation looks good

good presentation, Fred told that duration is IMV's strong point...and...

September 1, 2020

IMVIF

New presentation looks good

In 30 minutes the virtual presentation starts. The new presentation is up: ...

September 1, 2020

IMVIF

RE:Vaccine Upside

VXRT just sold their ATM facility for a whooping 90 mln... IMV needs to beat...

July 13, 2020

IMVIF

RE:RE:RE:Cancer vaccines reputations

$600 million, through the Strategic Innovation Fund, over two years to...

June 25, 2020

IMVIF

RE:RE:Cancer vaccines reputations

I agree, they need to make more noise. INO has pulled in the Bill Gatres...

June 25, 2020

1 2 3 4 5 6 7 8 9 10 Next

Featured Company

BioVaxys Technology Corp.

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »